![]() The situation has created a perfect storm for the company where it is benefiting on a number of different levels:.With almost 25 million Americans reporting that they have been diagnosed with COPD, the country’s third largest killer behind cancer and congestive heart failure, Viemed provides a solution for people who suffer from this debilitating disease.īeacon analyst Doug Cooper says Viemed is “right in the eye of the storm” of the pandemic and is benefiting from its ventilator and general pulmonary expertise. Viemed provides home respiratory services to patients struggling with various respiratory diseases including COPD and various neuromuscular diseases. Months, has increased its revenue forecast for the company and raised the price target on the stock to $12.50 from $9, giving it about 40% upside, while maintaining a “buy” rating. īeacon Securities, which has not conducted investing banking with VMD within the last 12 After the battering most stocks received during the pandemic panic, VMD fell to the $7 range and is now back to nearly $9. No cash balance or cash flow is included in the calculation.We first featured this company in early March of 2019 when the stock was trading around $7 a share. Please note all regulatory considerations regarding the presentation of fees must be taken into account. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Actual performance may differ significantly from backtested performance. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Backtested performance is developed with the benefit of hindsight and has inherent limitations. This information is provided for illustrative purposes only. No representations and warranties are made as to the reasonableness of the assumptions. ![]() ![]() Certain assumptions have been made for modeling purposes and are unlikely to be realized. Changes in these assumptions may have a material impact on the backtested returns presented. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested performance is not an indicator of future actual results. Disclaimer: The TipRanks Smart Score performance is based on backtested results.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |